Navigation Links
AMDL, Inc. Chairman & CEO Announces Expert Opinion on China's Economic Forecast
Date:1/26/2009

TUSTIN, Calif., Jan. 26 /PRNewswire-FirstCall/ -- (www.amdl.com) China continues to show significant potential to impact global markets according to AMDL, Inc. (NYSE Alternext US: ADL) Chairman and CEO Mr. Douglas MacLellan. The Company today announced the release of an internal economic forecast research report indicating China as having the #1 highest GDP growth rate in the world, eclipsing every other international market.

Mr. MacLellan has been working in China since 1983 and is a recognized authority on joint venture and wholly foreign owned enterprise (WFOE) structuring. He is a senior international business executive, economist, venture capitalist and merchant banker. MacLellan has been a catalyst for the development and financing of global businesses in the United States and throughout the world in countries that include: Bulgaria, Cambodia, Canada, Chile, China, Hungary, India, Korea, Madagascar and Russia over the past 16 years. Throughout his professional career, as a senior international business executive and or as a member of the board of directors of numerous companies, he has provided management, advice and counsel on strategic planning, operational activities, corporate finance, economic policy, asset allocation and mergers &acquisitions. He has helped raise over US$715 million for development stage, start-up and mid-cap companies. MacLellan holds extensive experience developing businesses in China, including a thorough understanding of the regulatory framework and how to work with local authorities. He has substantial contacts in the Chinese government and business communities.

To view Mr. MacLellan's report on the growing Chinese market visit www.amdl.com.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China.

    AMDL Contact:
    Kristine Szarkowitz
    Director-Investor Relations
    kszarkowitz@amdl.com
    (206) 310-5323


'/>"/>
SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
2. Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
3. AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 2009
4. Taxpayer Movement Urges Chairman Obey to Say No to Funding Abortion
5. Hospital Association Names New Chairman, Appoints Board Officers and New Members
6. Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board
7. RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board
8. Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies
9. DelSite Chairman George DeMott Resigns
10. Statement of DNC Chairman Howard Dean on World AIDS Day
11. Cardiome Discloses Chairman And CEOs Involuntary Share Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general dentist ... new pediatric patients, with or without a referral. Dr. Cotey knows that interceptive ... outcome and experience. When patients receive early treatment, they may achieve straight teeth with ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Curio Wellness ... to announce the finalization of the company’s executive management team with prominent executives from ... operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce ... million gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access ... MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, ... public to take the Diabetes Risk Test to find out if they are at ... World Airports will light up the evening sky by programming the LAX pylons the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  Experts in the field ... devices like  Soberlink Systems  as a model for ... published in early 2017, concluded that remote blood ... managing patient recovery." The findings of ... Addiction Medicine, detail a range of variables that ...
(Date:3/29/2017)... , March 29, 2017  The leader in accelerated ... Drs. Sam Daher , Manal Ibrahim , ... David Couchat will be the featured microlecture presenters at ... American Association of Orthodontists (AAO) Annual Session, April 21-25, ... the microlectures beginning daily at 11:20 a.m. On the ...
(Date:3/29/2017)... N.J. , March 29, 2017  Glenmark ... results for GSP 301, an investigational fixed-dose combination ... (665 mcg) administered twice-daily as a nasal spray ... rhinitis. These results are from a recently completed ... of GSP 301 combination therapy versus mometasone, olopatadine ...
Breaking Medicine Technology: